Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Normal embryonic development relies on the correct transmission of genetic information, and sperm DNA plays a crucial part in this process. Causes of poor sperm DNA integrity include unhealthy lifestyles such as smoking and exposure to gonadotoxins, as well as, obesity, varicoceles, infections, advanced paternal age and systemic disorders. An increase in DNA fragmentation in sperm has been linked to lower fertilisation rate, poorer quality embryos, lower pregnancy rate, and high miscarriages rate.
The best way for sperm selection and processing in assisted reproductive technologies (ART) should be noninvasive and cost-effective. It should also make it possible to identify high-quality spermatozoa and produce more favorable results in terms of pregnancy and live birth rates.7 Meanwhile, the microfluidic sperm separation technology is a less expensive and less invasive alternative. This method allows for the selection of motile sperm that have a normal morphology, low levels of reactive oxygen species (ROS), and low DFI
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| TESA-ICSI | Compare ICSI outcomes with high Sperm DNA fragmentation undergoing TESA (testicular sperm extraction) | ||
| Zymot-ICSI | Compare ICSI outcomes with high Sperm DNA fragmentation using microfluidic sperm separation device (Zymot) |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Clinical Pregnancy Rate | Compare clinical pregnancy rate in couples with high Sperm DNA fragmentation | approximately 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Number of utilizable blastocysts obtained | Compare the number of utilizable embryos obtained in couples using TESA-ICSI vs Zymot-ICSI | Approximately 20 days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
This retrospective study will compare and investigate ICSI outcomes in couples with high sperm DNA fragmentation using either testicular sperm (TESA) or microfluidic sperm separation device (Zymot)
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Armand Zini, MD | Clinique Ovo | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Clinique Ovo | Montreal | Quebec | H4P 2S4 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007248 | Infertility, Male |
| D053713 | Azoospermia |
| ID | Term |
|---|---|
| D005832 | Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007246 | Infertility |
Not provided
Not provided
Not provided
Not provided
Not provided
| D052801 |
| Male Urogenital Diseases |